Kelyniam Global, LLC

Kelyniam Global Announces Q2 and Q3 Earnings

Kelyniam Global, Inc. (OTC Pink: KLYG), an innovative medical device design and manufacturing company, posted its 2nd & 3rd quarter sales at $436,865 and $455,401 respectively. The reduction in quarterly revenue can be directly attributed to company resources allocated to its recent acquisition... - December 06, 2014